Skip to main content
. 2020 Aug 14;20:218. doi: 10.1186/s12890-020-01250-3

Table 2.

Radiological characteristics of lungs before drug therapy

Patients with indicated lung nodules n (%)
Size
Small nodule only single 7(12.0)
multiple 38(78.0)
Large nodule only 2(4.0)
Both small and large nodule 3(6.0)
Distribution
 Laterality
 Unilateral 16(32.0)
 Bilateral 34(68.0)
Lobe
 Upper lobe 6(12.0)
 Middle or lower lobe 12(24.0)
 Random 32(64.0)
Type
 Ground-glass nodule only 1(2.0)
 Solid nodule only 46(92.0)
 Both ground-glass and solid nodule 3(6.0)
Margin
 Irregular or untidy 6(12.0)
 Regular 44(88.0)
Second associated features
 Lobulation 3(6.0)
 Spiculation 3(6.0)
 Pleural retraction 2(4.0)
 Calcification 1(2.0)
Changes of nodules after treatments(n = 16)
 Smaller or disappear 10(20.0)
 No difference 6(12.0)
Other radiological features
 Ground-glass opacity 21(42.0)
 Thickening of pleura 9(18.0)
 Thickening of interlobular septa 4(8.0)
 Thickening of bronchial wall 3(6.0)
 Pleura effusion 4(8.0)
 Mass 3(6.0)
 Consolidation 1(2.0)
 Interstitial changes 5(6.0)
 Mediastinal and hilar lymphadenopathy 32(64.0)